Improving treatment for HIV and opioid use disorder with long-acting injections
Official title: Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder
Funded at Rhode Island Hospital · NIH-10795911 · Data updated 2026-11-12
This study is looking at how combining long-acting injectable treatments for both HIV and opioid use disorder can make it easier for people to stick to their medications and improve their health, so if you’re living with both conditions, this research might be for you!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | April 1, 2022 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $225,600 |
| NIH project number | 5R34DA055498-03 |
| Project ID | NIH-10795911 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with both HIV and opioid use disorder who may benefit from integrated treatment approaches.
✕Less likely to help
Patients who are not living with HIV or opioid use disorder may not receive any benefit from this research.
What this research studies
This research investigates how to better integrate treatment for individuals living with both HIV and opioid use disorder (OUD) by using long-acting injectable medications. The approach focuses on combining HIV and OUD treatments into a single care model to enhance medication adherence and improve health outcomes. By utilizing new injectable therapies, the study aims to reduce the burden of daily pill-taking, which can be a barrier for many patients. The research will explore the acceptability, feasibility, and safety of this integrated treatment approach across different populations and settings.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence and health outcomes for patients living with both HIV and opioid use disorder.
How similar studies have gone: Previous studies have shown promise in integrating treatments for HIV and OUD, suggesting that this approach could be effective.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Langdon, Kirsten Johnson — Rhode Island Hospital
- Study coordinator: Langdon, Kirsten Johnson
Related research
Other NIH-funded projects on the same topics.
-
A community treatment model to help young adults with opioid use disorder stick to their medication
This study is all about helping young adults with opioid use disorder stick to their medication by using a friendly support system that includes home delivery, family involvement, and fun incentives to keep them engaged and motivated in their recovery.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.